Fayetteville, AR — Cellia Science, Inc. proudly announces that Dr. Wilbur Lam, MD, PhD, Chief Medical Officer and distinguished scientist in the field of diagnostics and biomedical engineering, has been elected to the National Academy of Medicine (NAM). This prestigious recognition is a testament to Dr. Lam's exceptional contributions in the realms of point-of-care diagnostics and development of platforms to study cellular mechanics and blood biophysics.
NAM focuses on pivotal challenges in health, science, medicine, and related policies, catalyzing constructive initiatives across multiple sectors. Working collaboratively with the National Academy of Sciences and National Academy of Engineering, NAM offers impartial, objective analysis and guidance to the nation, engaging in multifaceted problem-solving and aiding informed public policy decisions. Additionally, the National Academies of Sciences, Engineering, and Medicine actively promote education, research, acknowledge exceptional contributions to knowledge, and advance public comprehension of STEMM. Election to NAM is widely regarded as one of the highest honors within the health and medicine domains, honoring individuals who showcase remarkable professional achievement and a strong commitment to service.
In the announcement of his election, NAM recognized Dr. Lam for “outstanding contributions in point-of-care, home-based, and/or smartphone-enabled diagnostics that are changing the management of pediatric and hematologic diseases as well as development of microsystems technologies as research-enabling platforms to investigate blood biophysics.” Furthermore, it was also noted that he “leads national/NIH efforts to assess diagnostic tests (including those for COVID-19) for the entire country.”
In addition to his role at Cellia Science, Dr. Lam is also the W. Paul Bowers Research Chair at the Wallace H. Coulter Department of Biomedical Engineering and serves as a Professor of Pediatrics and Associate Dean of Innovation at Emory University School of Medicine. His dedication and leadership have played a pivotal role in leading national and NIH efforts to assess diagnostic tests, including critical evaluations for COVID-19, for the entire nation. His contributions to the field have been instrumental in advancing healthcare and saving lives, especially in the face of the ongoing global pandemic.
Cellia Science is immensely proud to have Dr. Lam as our Chief Medical Officer, and we extend our warmest congratulations on this well-deserved recognition. His induction into the National Academy of Medicine further exemplifies his dedication to innovation, research, and the pursuit of excellence in healthcare.
About Cellia Science
Cellia Science is committed to developing innovative diagnostic solutions that transform healthcare. The company was founded in 2021 to address unmet needs in hematology with their label-free deep-UV imaging technology. To learn more, visit celliasci.com
About VIC Tech
VIC Tech is a technology venture development firm that creates innovative new companies with world-changing science- and engineering-based technologies. VIC carefully selects and licenses technologies from universities and research institutions around the world, then partners technology entrepreneurs with VIC’s team of business and technology experts and allocates seed capital through the nationally comprised VIC Investor Network. VIC provides its portfolio companies with senior management expertise, extensive knowledge of technology startups, and proven processes to execute business strategies, including legal, financial, operations, marketing, capital acquisition, and technology management. For more information, please visit victech.com